Article
Randomized clinical trial shows no substantial modulation of empathy-related neural activation by intranasal oxytocin in autism.
Scientific reports - 23 Jul 2021
Mayer Annalina V, Wermter Anne-Kathrin, Stroth Sanna, Alter Peter, Haberhausen Michael, Stehr Thomas, Paulus Frieder M, Krach Sören, Kamp-Becker Inge
Abstract excerpt
Evidence suggests that intranasal application of oxytocin facilitates empathy and modulates its underlying neural processes, which are often impaired in individuals with autism spectrum disorders (ASD). Oxytocin has therefore been considered a promising candidate for the treatment of social difficulties in ASD. However, evidence linking oxytocin treatment to social behavior and brain function in ASD is limited...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.